Henan Lingrui Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600285.SS

Henan Lingrui Pharmaceutical Co., Ltd. Free Cash Flow Yield on January 14, 2025: 6.80%

Henan Lingrui Pharmaceutical Co., Ltd. Free Cash Flow Yield is 6.80% on January 14, 2025, a -16.66% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Henan Lingrui Pharmaceutical Co., Ltd. 52-week high Free Cash Flow Yield is 8.74% on January 22, 2024, which is 28.56% above the current Free Cash Flow Yield.
Henan Lingrui Pharmaceutical Co., Ltd. 52-week low Free Cash Flow Yield is 5.27% on October 08, 2024, which is -22.43% below the current Free Cash Flow Yield.
Henan Lingrui Pharmaceutical Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 6.47%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 600285.SS

Henan Lingrui Pharmaceutical Co., Ltd.

CEO	Mr. Wei Xiong
IPO Date	Oct. 18, 2000
Location	China
Headquarters	No.666 Jiangjun Road
Employees	2,530
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

Key trends

Past 5 years